Financhill
Back

Rise Gold Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
47

RYES
Rise Gold

Last Price:
$0.10
Seasonality Move:
-14.99%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$54.42
Seasonality Move:
12.51%
Sell
47
Rise Gold (RYES) is a Sell

Is Rise Gold a Buy, Sell or Hold?

  • The current Rise Gold [RYES] share price is $0.10. The Score for RYES is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RYES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $53.94. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RYES Stock Price Chart

What is Rise Gold's stock price today?

  • The Rise Gold share price today is $0.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYES is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $53.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

RYES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 60.99 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.06 - 0.1) Buy
Bollinger Bands (100): (0.07 - 0.09) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.59 Sell
Relative Strength Index (14 RSI): 31.57 Sell
Chaikin Money Flow: -108555 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.57 - 82.31) Sell
Bollinger Bands (100): (80.58 - 128.2) Sell

RYES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.08 Buy
20-day SMA: 0.08 Buy
50-day SMA: 0.07 Buy
200-day SMA: 0.1 Sell
8-day EMA: 0.09 Buy
20-day EMA: 0.08 Buy
50-day EMA: 0.07 Buy
200-day EMA: 0.1 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.71 Buy
20-day SMA: 61.78 Sell
50-day SMA: 87.56 Sell
200-day SMA: 119.05 Sell
8-day EMA: 54.67 Sell
20-day EMA: 63.17 Sell
50-day EMA: 81.41 Sell
200-day EMA: 108.77 Sell

Rise Gold Earnings Growth & RYES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.

Rise Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):